CD274 and neoplasm: Tumor growth was also significantly decreased with combination of RT and anti-PD-L1 in TUBO breast cancer mouse model (RT plus PD-L1 blockade vs. RT: 25.59 ± 10.26 mm vs. 402.8 ± 76.73 mm, p = 0.0002) [12].